Norihiro Watanabe

7PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical roboticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 27, 2026
Engineering CAR-Vδ2 T cells to boost persistence and anti-tumor function.

|Jan 25, 2025
Novel B7-H3 CAR T cells show potent antitumor effects in glioblastoma: a preclinical study.

Thananya Inthanachai, Chatikorn Boonkrai, Tanapati Phakham

|Jan 19, 2024
Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia.

Wingchi K Leung, Alejandro G Torres Chavez, Matthew French-Kim

|Aug 31, 2022
Engineering T cells to suppress acute GVHD and leukemia relapse after allogeneic hematopoietic stem cell transplantation.

Feiyan Mo, Norihiro Watanabe, Kayleigh I Omdahl

|Jul 15, 2020
Engineered off-the-shelf therapeutic T cells resist host immune rejection.

Feiyan Mo, Norihiro Watanabe, Mary K McKenna

|Nov 30, 2019
Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity.

Alejandro Torres Chavez, Mary Kathryn McKenna, Emanuele Canestrari

Pageof 2

Frequent Collaborators

3 joint publications

Maksim Mamonkin

1 joint publications

Diogo Gomes-Silva

1 joint publications

Feiyan Mo

1 joint publications

Kayleigh I Omdahl